Restore Harmony. Extend Healthspan.

Developing first-in-class mitochondrial complex I modulators (MCMs)

Istesso is rethinking how we extend healthspan as we age. Rather than trying to stop or slow disease progression, we focus on restoring the body’s natural capacity to repair itself and return to health.

Our pioneering approach centers on mitochondrial Complex I modulators, or MCMs, a new class of oral small molecule drugs that repair and regenerate tissue across multiple organs and disease settings. Our lead clinical program, leramistat, is in Phase 2 trials, and we are expanding MCMs to other chronic diseases of aging with a pipeline of assets, each holding blockbuster potential.

Our pipeline

"It’s hard to imagine anything more rewarding than translating exciting science into treatments with the potential to benefit patients."

A smiling woman with dark brown hair and a navy blue blazer sits in front of an orange background.

Lisa Patel

Chief Executive Officer

Latest news

Istesso
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

More information about our Privacy Policy